Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hur, Seung-Ho | - |
dc.contributor.author | Kim, In-Cheol | - |
dc.contributor.author | Won, Ki-Bum | - |
dc.contributor.author | Cho, Yun-Kyeong | - |
dc.contributor.author | Yoon, Hyuck-Jun | - |
dc.contributor.author | Nam, Chang-Wook | - |
dc.contributor.author | Kim, Kwon-Bae | - |
dc.contributor.author | Kim, Min-Seok | - |
dc.contributor.author | Park, Jincheol | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Chae, Shung-Chull | - |
dc.contributor.author | Kim, Young-Jo | - |
dc.contributor.author | Kim, Chong-Jin | - |
dc.contributor.author | Cho, Myeong-Chan | - |
dc.contributor.author | Jeong, Myung-Ho | - |
dc.contributor.author | Ahn, Young-Keun | - |
dc.contributor.author | Kim, Hyo-Soo | - |
dc.contributor.author | Ahn, Tae-Hoon | - |
dc.contributor.author | Seung, Ki-Bae | - |
dc.contributor.author | Jang, Yangsoo | - |
dc.contributor.author | Yoon, Jung-Han | - |
dc.contributor.author | Seong, In-Whan | - |
dc.contributor.author | Hong, Taek-Jong | - |
dc.contributor.author | Bae, Jang-Ho | - |
dc.contributor.author | Park, Seung-Jung | - |
dc.date.available | 2020-02-28T01:46:23Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-05 | - |
dc.identifier.issn | 0160-9289 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8328 | - |
dc.description.abstract | Background: Despite improved long-term safety of biodegradable polymer (BP) drug-eluting stents (DES) compared to first-generation durable polymer (DP) DES, data on the safety and efficacy of BP-DES compared with second-generation (2G) DP-DES in patients with acute myocardial infarction (AMI) are limited. Hypothesis: To evaluate the safety and efficacy of BP-DES compared with 2G-DP-DES in the higher stent thrombosis (ST) risk setting of AMI. Methods: A total of 3359 AMI patients who received either BP-DES (n=261) or 2G-DP-DES (n=3098) were included from the Korea Acute Myocardial Infarction Registry (KAMIR). Differences in baseline clinical and angiographic characteristics were adjusted using a 1:5 propensity score matching analysis (n=261 for BP-DES and n=1305 for 2G-DP-DES). The primary outcome was the incidence of major adverse cardiac events (MACE) including all-cause death, recurrent myocardial infarction (re-MI), and target vessel revascularization (TVR). The rate of definite or probable ST was also investigated. Results: In adjusted analysis, there was no significant difference between the 2 groups in baseline clinical and angiographic characteristics; 2-year MACE (10.7% and 9.9% in the BP-DES group and 2G-DP-DES group, respectively, P =0.679); ST incidence (0.8% vs 0.9%, respectively, P =1.0), and rates of all-cause death, re-MI, and TVR. By multivariate analysis, old age, diabetes mellitus, renal dysfunction, and left ventricular dysfunction were the independent predictors of MACE after BP-DES or 2G-DP-DES implantation. Conclusions: BP-DES and 2G-DP-DES appear to have comparable 2-year safety and efficacy for the treatment of AMI. However, longer-term follow-up is needed. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.relation.isPartOf | CLINICAL CARDIOLOGY | - |
dc.subject | BARE-METAL STENTS | - |
dc.subject | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject | RANDOMIZED CONTROLLED-TRIALS | - |
dc.subject | VASCULAR-RESPONSE | - |
dc.subject | THROMBOSIS | - |
dc.subject | METAANALYSIS | - |
dc.subject | DISEASE | - |
dc.subject | CYPHER | - |
dc.title | Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR) | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000379922900005 | - |
dc.identifier.doi | 10.1002/clc.22525 | - |
dc.identifier.bibliographicCitation | CLINICAL CARDIOLOGY, v.39, no.5, pp.276 - 284 | - |
dc.identifier.scopusid | 2-s2.0-84963579228 | - |
dc.citation.endPage | 284 | - |
dc.citation.startPage | 276 | - |
dc.citation.title | CLINICAL CARDIOLOGY | - |
dc.citation.volume | 39 | - |
dc.citation.number | 5 | - |
dc.contributor.affiliatedAuthor | Ahn, Tae-Hoon | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | BARE-METAL STENTS | - |
dc.subject.keywordPlus | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIALS | - |
dc.subject.keywordPlus | VASCULAR-RESPONSE | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | CYPHER | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.